Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Wave Life Sciences logo — Unlocking the broad potential of RNA medicines to transform...

Wave Life Sciences

Unlocking the broad potential of RNA medicines to transform human health

Founded 2012 United States Cambridge, United States 379 employees Post-IPO Equity Biotechnology, Health Care +2

General Information

Company Name Wave Life Sciences
Founded Year 2012
Location United States Cambridge, United States
Employees 379
Industries Biotechnology, Health Care, Health and Wellness +1
Funding Stage Post-IPO Equity
Social

BounceWatch is an independent company data service, not affiliated with Wave Life Sciences. To contact Wave Life Sciences, visit wavelifesciences.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Wave Life Sciences compare?

A PDF of Wave Life Sciences and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Wave Life Sciences soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Wave Life Sciences

Wave Life Sciences is a biotechnology company with a powerful vision to transform human health by unlocking the broad potential of RNA medicines. The company's RNA medicines platform, PRISM, integrates various modalities, chemistry innovation, and deep insights into human genetics to bring about scientific breakthroughs addressing both rare and prevalent disorders. This platform includes RNA-targeting modalities such as editing, splicing, RNA interference, and antisense silencing, providing the company with unparalleled capabilities to design and deliver candidates that effectively tackle disease biology. Wave Life Sciences has a diverse pipeline of clinical programs focusing on Duchenne muscular dystrophy, Alpha-1 antitrypsin deficiency, Huntington’s disease, and a preclinical program in obesity. The company's commitment to "Reimagine Possible" is reflected in its dedication to adapting human potential free from the burden of disease. Founded in 2012, the company operates primarily in the Biotechnology, Health Care, Health and Wellness, and Pharmaceutical industries. Its most recent milestone was a significant Post-IPO Equity investment on 24 September 2024, which signifies continued confidence in the company's potential for positive impact on human health.

Business keywords: Genetic Medicines, RNA Editing, RNA Interference, Oligonucleotides, Drug Development, Therapeutic Modalities, Rare Disorders, Precision Medicine, Clinical Stage, Disease Biology, Human Genetics, Life-changing Treatments, Precision Design, Stereopure Oligonucleotides

Funding Rounds & Investors (10)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Equity Undisclosed -
24 Sep 2024
Post IPO Equity Undisclosed -
07 Dec 2023
Post IPO Equity Undisclosed -
13 Dec 2022
Post IPO Equity Undisclosed -
14 Jun 2022
Post IPO Equity Undisclosed -
23 Jan 2019
Post IPO Equity Undisclosed -
20 Feb 2018
Post IPO Equity Undisclosed -
01 Apr 2017
Post IPO Equity Undisclosed -
14 Dec 2015
Series B Undisclosed -
18 Aug 2015
Series A Undisclosed -
02 Feb 2015

Latest News

View All
FDA reversals leave investors worrying about the fates of other experimental drugs — Cnbc
FDA reversals leave investors worrying about the fates of other experimental drugs
Cnbc Mar 06, 2026
What obesity drugmakers see next in the market: More pills, easier access and drug combinations — Cnbc
What obesity drugmakers see next in the market: More pills, easier access and drug combinations
Cnbc Jan 23, 2026

Wave Life Sciences Alternatives & Competitors

View All Alternatives
Wave Life Sciences vs
Locanabio, Inc.
Locanabio, Inc. United States

Creating RNA-targeting gene therapies to treat devastating diseases

Series B
7 employees
Biotechnology, Health Care
Compare Wave Life Sciences vs Locanabio, Inc.
Wave Life Sciences vs
Reborna Biosciences, Inc.
Reborna Biosciences, Inc. Japan

Save the life of rare disease patients and the parents by RNA binding molecules.

Seed
7 employees
Biotechnology, Health Care
Wave Life Sciences vs
Autifony Therapeutics
Autifony Therapeutics

Autifony are dedicated to developing new medicines to treat rare genetic CNS disorders

Venture round
37 employees
Biotechnology, Health and Wellness
Also compare with: Wave Life Sciences vs Ascidian Therapeutics Ascidian Therapeutics View all alternatives

FAQ About Wave Life Sciences

Unlocking the broad potential of RNA medicines to transform human health
Wave Life Sciences was founded in 2012.
Wave Life Sciences is headquartered in Cambridge, United States.
Wave Life Sciences operates in Biotechnology, Health Care, Health and Wellness and Pharmaceutical. Its work centres on Genetic Medicines, RNA Editing, RNA Interference and Oligonucleotides.
Wave Life Sciences has approximately 379 employees.
Wave Life Sciences has completed 10 funding rounds. The latest funding stage is Post-IPO Equity.
Top alternatives and competitors to Wave Life Sciences include Locanabio, Inc., Reborna Biosciences, Inc., Autifony Therapeutics, Ascidian Therapeutics, Autotelic Bio Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Wave Life Sciences and Locanabio, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Wave Life Sciences, https://bouncewatch.com/company/wave-life-sciences, updated 9 June 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes